Organization
Novustat GmbH
1 abstract
Abstract
No checkmate in metastatic setting: Navigating real world patients applying personalized therapy based on extensive tumor profiling.Org: Datar Cancer Genetics Europe GmbH, Datar Cancer Genetics, Novustat GmbH,